Krebs Biochemicals & Industries Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 209.43 million compared to INR 119.8 million a year ago. Revenue was INR 212.17 million compared to INR 121.12 million a year ago. Net loss was INR 40.61 million compared to INR 108.49 million a year ago. Basic loss per share from continuing operations was INR 1.88 compared to INR 5.05 a year ago. Diluted loss per share from continuing operations was INR 1.88 compared to INR 5.05 a year ago.
For the six months, sales was INR 315.83 million compared to INR 187.36 million a year ago. Revenue was INR 319.87 million compared to INR 188.97 million a year ago. Net loss was INR 121.98 million compared to INR 202.72 million a year ago. Basic loss per share from continuing operations was INR 5.66 compared to INR 9.42 a year ago. Diluted loss per share from continuing operations was INR 5.66 compared to INR 9.42 a year ago.